Autor(es)

Bolsoni, Livia Maria ; Crippa, Jose Alexandre S. ; Cecilio Hallak, Jaime Eduardo ; Guimaraes, Francisco Silveira ; Zuardi, Antonio Waldo

• Tipo de documento: Artigo Científico
• Fonte: Revista Brasileira de Psiquiatria; v. 44, n. 3, p. 10-pg., 2022-05-01.

Resumo

Objectives: We assessed whether administering cannabidiol (CBD) before recalling the traumatic event that triggered their disorder attenuates anxiety in patients with post-traumatic stress disorder (PTSD). As an exploratory pilot analysis, we also investigated whether this effect depends on the nature of the event (sexual vs. nonsexual trauma). Methods: Thirty-three patients of both sexes with PTSD were recruited and randomized 1:1 into two groups. One group received oral CBD (300 mg), and the other received a placebo before listening to a digital audio playback of their previously recorded report of the trigger event. Subjective and physiological measurements were taken before and after recall. We analyzed the data in two subsamples: trigger events involving sexual and nonsexual trauma. Results: In the nonsexual trauma group, the differences between measurements before and after recall were significantly smaller with CBD than placebo; this held true for anxiety and cognitive impairment. However, in the sexual trauma group, the differences were non-significant for both measurements. Conclusion: A single dose of CBD (300mg) attenuated the increased anxiety and cognitive impairment induced by recalling a traumatic event in patients with PTSD when the event involved nonsexual trauma. (AU)

• Processo FAPESP: 20/05416-4 - Estratégias experimentais na investigação da anosmia induzida pelo COVID-19: há um componente neurodegenerativo envolvido?
• Beneficiário: Alline Cristina de Campos
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 16/01801-5 - Uso do Canabidiol na reconsolidação de memórias aversivas em vítimas de TEPT.
• Beneficiário: Lívia Maria Bolsoni
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 08/09009-2 - Uso crônico de crack: densidade de transportador de dopamina, fatores genéticos e funcionamento executivo.
• Beneficiário: Acioly Luiz Tavares de Lacerda
• Modalidade de apoio: Auxílio à Pesquisa - Regular